In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 20th, 2008 | 35 | Yes |
Popular Name: 1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)phenyl]urea 1-[5-tert-butyl-2-(p-tolyl)pyraz…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.32 | 9.99 | -18.22 | 2 | 8 | 0 | 81 | 477.609 | 8 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1800 | 0.23 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 88 | 0.28 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 88 | 0.28 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 88 | 0.28 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 88 | 0.28 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.21 | Functional ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.21 | Functional ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.21 | Functional ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.21 | Functional ≤ 10μM |
Z80548-1-O | THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other | Other | 6200 | 0.21 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 300 | 0.26 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 310 | 0.26 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 310 | 0.26 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 310 | 0.26 | Binding ≤ 1μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 1800 | 0.23 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 2300 | 0.23 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 310 | 0.26 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 310 | 0.26 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 310 | 0.26 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 6200 | 0.21 | Functional ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 6200 | 0.21 | Functional ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 6200 | 0.21 | Functional ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 6200 | 0.21 | Functional ≤ 10μM |
Z80548 | Z80548 | THP-1 (Acute Monocytic Leukemia Cells) | 6200 | 0.21 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
DSCAM interactions | |
ERK/MAPK targets | |
FCERI mediated MAPK activation | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
KSRP destabilizes mRNA | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet sensitization by LDL | |
VEGFA-VEGFR2 Pathway |